Asymmetric Hydrogenation of 2,4-Disubstituted 1,5-Benzodiazepines Using Cationic Ruthenium Diamine Catalysts: An Unusual Achiral Counteranion Induced Reversal of Enantioselectivity

被引:114
作者
Ding, Zi-Yuan [1 ,2 ]
Chen, Fei [1 ,2 ]
Qin, Jie [1 ,2 ]
He, Yan-Mei [1 ,2 ]
Fan, Qing-Hua [1 ,2 ]
机构
[1] Chinese Acad Sci, Beijing Natl Lab Mol Sci, CAS Key Lab Mol Recognit & Funct, Inst Chem, Beijing 100190, Peoples R China
[2] Chinese Acad Sci, Grad Sch, Beijing 100190, Peoples R China
基金
中国国家自然科学基金;
关键词
1,5-benzodiazepine; asymmetric catalysis; diamine ligands; hydrogenation; ruthenium; C(2)-SYMMETRIC COPPER(II) COMPLEXES; CHIRAL LEWIS-ACIDS; RECEPTOR ANTAGONISTS; CARBONYL-COMPOUNDS; ALDOL ADDITIONS; LIGANDS; IMINES; ENOLSILANES; ENANTIOMERS; POLYMERASE;
D O I
10.1002/anie.201200309
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
BArFing it out the other way: A highly enantioselective hydrogenation of 2,4-disubstituted 1,5-benzodiazepines using chiral cationic ruthenium diamine catalysts (R,R)-1 has been developed (see scheme; BArF=tetrakis(3,5- bistrifluoromethylphenyl)borate). Either enantiomer of 2,4-diaryl-2,3,4,5- tetrahydro-1H-benzodiazepine derivatives could be obtained by using the same enantiomer of ligand but in the presence of a different achiral counteranion. Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
引用
收藏
页码:5706 / 5710
页数:5
相关论文
共 100 条
  • [61] INHIBITION OF HIV-1 REPLICATION BY A NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR
    MERLUZZI, VJ
    HARGRAVE, KD
    LABADIA, M
    GROZINGER, K
    SKOOG, M
    WU, JC
    SHIH, CK
    ECKNER, K
    HATTOX, S
    ADAMS, J
    ROSEHTHAL, AS
    FAANES, R
    ECKNER, RJ
    KOUP, RA
    SULLIVAN, JL
    [J]. SCIENCE, 1990, 250 (4986) : 1411 - 1413
  • [62] Nadendla R. R., 2005, PRINCIPLES ORGANIC M, p[74, 83, 111]
  • [63] Synergistic effects of hemilabile coordination and counterions in homogeneous catalysis: New tunable monophosphine ligands for hydrovinylation reactions
    Nandi, M
    Jin, J
    RajanBabu, TV
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1999, 121 (42) : 9899 - 9900
  • [64] Nawrocka W, 2001, ARCH PHARM, V334, P3, DOI 10.1002/1521-4184(200101)334:1<3::AID-ARDP3>3.0.CO
  • [65] 2-2
  • [66] 1,5-Benzodiazepines, a Novel Class of Hepatitis C Virus Polymerase Nonnucleoside Inhibitors
    Nyanguile, Origene
    Pauwels, Frederik
    Van den Broeck, Walter
    Boutton, Carlo W.
    Quirynen, Ludo
    Ivens, Tania
    van der Helm, Liesbet
    Vandercruyssen, Genevieve
    Mostmans, Wendy
    Delouvroy, Frederic
    Dehertogh, Pascale
    Cummings, Maxwell D.
    Bonfanti, Jean-Francois
    Simmen, Kenneth A.
    Raboisson, Pierre
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (12) : 4420 - 4431
  • [67] The hydrogenation/transfer hydrogenation network:: Asymmetric hydrogenation of ketones with chiral η6-arene/N-tosylethylenediamine-ruthenium(II) catalysts
    Ohkuma, Takeshi
    Utsumi, Noriyuki
    Tsutsumi, Kunihiko
    Murata, Kunihiko
    Sandoval, Christian
    Noyori, Ryoji
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (27) : 8724 - 8725
  • [68] Ohtake Y., 2007, EP 1820799 A1, Patent No. 1820799
  • [69] A new approach to switching of enantioselectivity in NHC-Cu-catalyzed conjugate addition of alkylzincs to cyclic enones
    Okamoto, Masaki
    Yamamoto, Yuko
    Sakaguchi, Satoshi
    [J]. CHEMICAL COMMUNICATIONS, 2009, (47) : 7363 - 7365
  • [70] Optically active iridium imidazol-2-ylidene-oxazoline complexes: Preparation and use in asymmetric hydrogenation of arylalkenes
    Perry, MC
    Cui, XH
    Powell, MT
    Hou, DR
    Reibenspies, JH
    Burgess, K
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (01) : 113 - 123